No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CGEM Cullinan Therapeutics
- 10.950
- +0.180+1.67%
Close Dec 19 16:00 ET
- 10.950
- 0.0000.00%
Pre 04:46 ET
637.59MMarket Cap-3.86P/E (TTM)
11.120High10.440Low625.13KVolume10.940Open10.770Pre Close6.81MTurnover1.62%Turnover RatioLossP/E (Static)58.23MShares30.18952wk High1.02P/B422.01MFloat Cap9.24052wk Low--Dividend TTM38.54MShs Float59.850Historical High--Div YieldTTM6.31%Amplitude7.300Historical Low10.895Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Clear Street Launches Healthcare & Biotechnology Equity Research
Top Premarket Decliners
Adobe, Keros Therapeutics, Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Cullinan Therapeutics Announces Q3 2024 Progress and Outlook
We're Not Very Worried About Cullinan Therapeutics' (NASDAQ:CGEM) Cash Burn Rate
Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36
Heat List
US
Overall
Symbol
Price
% Chg
No Data